Literature DB >> 20656228

Cryoablation: mechanism of action and devices.

Joseph P Erinjeri1, Timothy W I Clark.   

Abstract

Cryoablation refers to all methods of destroying tissue by freezing. Cryoablation causes cellular damage, death, and necrosis of tissues by direct mechanisms, which cause cold-induced injury to cells, and indirect mechanisms, which cause changes to the cellular microenvironment and impair tissue viability. Cellular injury, both indirect and direct, can be influenced by four factors: cooling rate, target temperature, time at target temperature, and thawing rate. In this review, the authors describe the mechanisms of cellular injury that occur with cryoablation, the major advantages and disadvantages of cryoablation compared with other thermal ablation techniques, and the current commercially available cryoablation ablation systems. Copyright (c) 2010 SIR. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20656228      PMCID: PMC6661161          DOI: 10.1016/j.jvir.2009.12.403

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN: 1051-0443            Impact factor:   3.464


  63 in total

Review 1.  Percutaneous ablation of colorectal lung metastases.

Authors:  Carole A Ridge; Stephen B Solomon
Journal:  J Gastrointest Oncol       Date:  2015-12

2.  Combined magnetic resonance imaging and optical surgical navigation system guidance of percutaneous liver cryoablation in a porcine model.

Authors:  Kang Zhou; Zhuoli Zhang; Matteo Figini; Junjie Shangguan; Yining Wang; Haifeng Shi; Yumei Li; Zhengyu Jin; Jie Pan
Journal:  Am J Transl Res       Date:  2018-05-15       Impact factor: 4.060

3.  Cryoablation in fibro-adipose vascular anomaly (FAVA): a minimally invasive treatment option.

Authors:  Raja Shaikh; Ahmad I Alomari; Cindy L Kerr; Patricia Miller; Samantha A Spencer
Journal:  Pediatr Radiol       Date:  2016-02-22

4.  Percutaneous cryoablation in early stage hepatocellular carcinoma: analysis of local tumor progression factors.

Authors:  Dong Kyu Kim; Kichang Han; Jong Yun Won; Gyoung Min Kim; Joon Ho Kwon; Man Deuk Kim
Journal:  Diagn Interv Radiol       Date:  2020-03       Impact factor: 2.630

Review 5.  Percutaneous Image-Guided Cryoablation in Vascular Anomalies.

Authors:  Raja Shaikh
Journal:  Semin Intervent Radiol       Date:  2017-09-11       Impact factor: 1.513

Review 6.  Local treatment of oligometastatic disease: current role.

Authors:  Moritz T Winkelmann; Stephan Clasen; Philippe L Pereira; Rüdiger Hoffmann
Journal:  Br J Radiol       Date:  2019-06-06       Impact factor: 3.039

7.  Point/counterpoint. Therapeutic rather than diagnostic medical physicists should lead the development and clinical implementation of image-guided nonionizing therapeutic modalities such as MR-guided high-intensity ultrasound.

Authors:  Wolfgang A Tomé; R Jason Stafford; Colin G Orton
Journal:  Med Phys       Date:  2013-03       Impact factor: 4.071

Review 8.  Thermal ablation of stage I non-small cell lung carcinoma.

Authors:  Carol A Ridge; Stephen B Solomon; Raymond H Thornton
Journal:  Semin Intervent Radiol       Date:  2014-06       Impact factor: 1.513

Review 9.  [Ablative therapy of small renal masses].

Authors:  M C Kriegmair; N Wagener; S J Diehl; N Rathmann
Journal:  Urologe A       Date:  2018-03       Impact factor: 0.639

10.  European Thyroid Association and Cardiovascular and Interventional Radiological Society of Europe 2021 Clinical Practice Guideline for the Use of Minimally Invasive Treatments in Malignant Thyroid Lesions.

Authors:  Giovanni Mauri; Laszlo Hegedüs; Steven Bandula; Roberto Luigi Cazzato; Agnieszka Czarniecka; Oliver Dudeck; Laura Fugazzola; Romana Netea-Maier; Gilles Russ; Göran Wallin; Enrico Papini
Journal:  Eur Thyroid J       Date:  2021-05-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.